FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385564000: Drotrecogin alfa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1459743014 Drotrecogin alfa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1479769016 Drotrecogin alfa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
807701000172113 drotrécogine alpha fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Drotrecogin alfa (substance) Is a Recombinant human activated protein c (substance) true Inferred relationship Some
Drotrecogin alfa (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Coagulation factor inhibitor (disposition) false Inferred relationship Some
Drotrecogin alfa (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protease inhibitor protein (disposition) true Inferred relationship Some
Drotrecogin alfa (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Activated coagulation factor (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing drotrecogin alfa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drotrecogin alfa (substance) Inferred relationship Some 1
Drotrecogin alfa 5 mg powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Drotrecogin alfa (substance) Inferred relationship Some
Drotrecogin alfa 20mg powder for infusion solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Drotrecogin alfa (substance) Inferred relationship Some
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Drotrecogin alfa (substance) Inferred relationship Some 1
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Drotrecogin alfa (substance) Inferred relationship Some 1
Product containing drotrecogin alfa in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drotrecogin alfa (substance) Inferred relationship Some 1
Product containing only drotrecogin alfa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drotrecogin alfa (substance) Inferred relationship Some 1
Drotrecogin alfa only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drotrecogin alfa (substance) Inferred relationship Some 1
Drotrecogin alfa 5 mg powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Drotrecogin alfa (substance) Inferred relationship Some 1
Drotrecogin alfa 5 mg powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Drotrecogin alfa (substance) Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start